Clinical Trial Update: Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis(RA) [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates the safety of FURESTEM-RA injections in patients with moderate to severe rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• FURESTEM-RA

Snippet

Sponsor: Kang Stem Biotech Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED